Plump Andrew Stewart
SEC insider (Form 3/4/5 filer). CIK 0001977689. President, R&D at TAKEDA PHARMACEUTICAL CO LTD (TAK). 5 reported Form 4/5 transactions since Sep 2024; latest on Sep 2, 2026. Located in CAMBRIDGE, MA.
Companies Plump Andrew Stewart has filed insider reports for
- TAKEDA PHARMACEUTICAL CO LTD (TAK): Director, Officer, President, R&D
Plump Andrew Stewart
CIK: 0001977689
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (60.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TAK
TAKEDA PHARMACEUTICAL CO LTD
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Sep 2, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
SaleIndirect116.2K shares at avg. $18.49$2.1M - Aug 19, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
SaleIndirect19.7K shares at avg. $18.49$363K - Aug 10, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
SaleDirect165.4K shares at avg. $17.10$2.8M - Jul 1, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
AwardDirect125.4K shares- - Apr 27, 2026TAK
TAKEDA PHARMACEUTICAL CO LTD
AwardDirect212.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 2, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | Sale | 116,191 | $18.49 | $2,148,372 | Indirect |
| Aug 19, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | Sale | 19,651 | $18.49 | $363,347 | Indirect |
| Aug 10, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | Sale | 165,393 | $17.10 | $2,828,220 | Direct |
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | Award | 125,390 | - | $0 | Direct |
| Apr 27, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | Award | 212,470 | - | $0 | Direct |
1-5 of 5 transactions